Attitudes toward Post‐Trial Access to Medical Interventions: A Review of Academic Literature,Legislation, and International Guidelines

There is currently no international consensus around post‐trial obligations toward research participants, community members, and host countries. This literature review investigates arguments and attitudes toward post‐trial access. The literature review found that academic discussions focused on the rights of research participants, but offered few practical recommendations for addressing or improving current practices. Similarly, there are few regulations or legislation pertaining to post‐trial access. If regulatory changes are necessary, we need to understand the current arguments, legislation, and attitudes towards post‐trial access and participants and community members. Given that clinical trials conducted in low‐income countries will likely continue, there is an urgent need for consideration of post‐trial benefits for participants, communities, and citizens of host countries. While this issue may not be as pressing in countries where participants have access to healthcare and medicines through public schemes, it is particularly important in regions where this may not be available.     

Classification of Chinese herbs based on the cluster analysis of delayed luminescence

Traditional Chinese material medica are an important component of the Chinese pharmacopeia. According to the traditional Chinese medicinal concept, Chinese herbal medicines are classified into different categories based on their therapeutic effects, however, the bioactive principles cannot be solely explained by chemical analysis. The aim of this study is to classify different Chinese herbs based on their therapeutic effects by using delayed luminescence (DL). The DL of 56 Chinese herbs was measured using an ultra‐sensitive luminescence detection system. The different DL parameters were used to classify Chinese herbs according to a hierarchical cluster analysis. The samples were divided into two groups based on their DL kinetic parameters. Interestingly, the DL classification results were quite consistent with classification according to the Chinese medicinal concepts of ‘cold’ and ‘heat’ properties. In this paper, we show for the first time that by using DL technology, it is possible to classify Chinese herbs according to the Chinese medicinal concept and it may even be possible to predict their therapeutic properties. Copyright © 2015 John Wiley & Sons, Ltd.     

The insights of Let‐7 miRNAs in oncogenesis and stem cell potency

The ability of the classic tumour‐suppressive let‐7 family to inhibit carcinogenesis, tumour progression, recurrence and pluripotency of cancer stem cells has generated significant interest in the field of cancer research. Through suppressing and degrading downstream‐targeted mRNAs, let‐7 affected most aspects of cell biology. It is perplexing how let‐7 affects oncogenesis, as the large influx of new miRNAs and other kinds of non‐coding RNAs are continuously defined. In this review, we delineate the complex functions of let‐7 and discuss the future direction of let‐7 research.     

苏州文人园林曲桥路径对视线引导的实验研究

选取3处苏州园林的曲桥路径,现场邀请游人取景拍照,获取其游园过程中关注景物、视线方向等信息,结合路径与景物关系,通过实验方法分析曲桥路径中游人赏景的视觉行为特征。通过定量分析发现,苏州文人园林中曲桥转折间带来的空间位置变化影响着人们的视觉行为,其中景物视距与方向对人们的观景兴致存在显著影响,视距在3~33 m时,游人观景兴致最佳;同时路径方向与观景方向的垂直关系、路径对景物的指向关系可增强游人对相应景观的观赏兴致,曲桥中对垂直与指向关系的运用存在一定的规律。     

Ethical issues associated with HIV phylogenetics in HIV transmission dynamics research: A review of the literature using the Emanuel Framework

The reduced costs of DNA sequencing and the use of such data for HIV‐1 clinical management and phylogenetic analysis have led to a massive increase of HIV‐1 sequences in the last few years. Phylogenetic analysis has shed light on the origin, spread and characteristics of HIV‐1 epidemics and outbreaks. Phylogenetic analysis is now also being used to advance our knowledge of the drivers of HIV‐1 transmission in order to design effective interventions. However, HIV phylogenetic analysis presents unique ethical challenges, which have not been fully explored. This review presents an analysis of what appear to be key ethical issues in HIV phylogenetics in the hope of stimulating further conceptual and empirical work in this rapidly emerging area. We structure the review using the Emanuel Framework, a systematic, holistic framework, which has been adapted for use in developing countries, which bear the brunt of the HIV‐1 pandemic.     

Drugging the undruggable proteins in cancer: A systems biology approach

In recent years, the research community has, with comprehensive systems biology approaches and related technologies, gained insight into the vast complexity of numerous cancers. These approaches allow an in-depth exploration that cannot be achieved solely using conventional low-throughput methods, which do not closely mimic the natural cellular environment. In this review, we discuss recent integrative multiple omics approaches for understanding and modulating previously identified ‘undruggable’ targets such as members of the RAS family, MYC, TP53, and various E3 ligases and deubiquitinases. We describe how these technologies have revolutionized drug discovery by overcoming an array of biological and technological challenges and how, in the future, they will be pivotal in assessing cancer states in individual patients, allowing for the prediction and application of personalized disease treatments.     

Global research trends and gaps in ecological compensation studies from 1990 to 2020: A scientometric review

Ecosystems are facing severe destruction and threats due to unreasonable human utilization. Repairing damage to nature and protect biodiversity through ecological compensation will be an inevitable measure for achieving sustainable development. To explore the current research hotspots and future research directions of ecological compensation, this paper tries to search the WoS Core Collection and collects 685 ecological compensation papers published between 1990 and 2020. R language and CiteSpace software were applied in this paper. It is found that: (1) The number of articles has gone through the initial explorations, fluctuating growth, and rapid development of the field from 1990 to 2020. Only 7.5% of authors have published more than two papers. (2) Regarding the production of papers, the top 3 countries are the US, China, and the UK. At present, the majority of countries focus on independent research, and international cooperation is gradually strengthening. (3) The current research hotpots mainly invlove biodiversity and sustainable development, ecological compensation for forests and water resources, China's Grain-to-Green Project, poverty reduction, livelihood issues, public participation willingness and equity issues, indicating that ecological compensation is a rapidly emerging interdisciplinary academic field. (4) The results reveal several research directions in the future: strengthening theoretical research, resolving issues pertaining to the complex relationships among stakeholders, encouraging a transformation from qualitative to quantitative research, increasing the focus of ecological compensation models on local conditions, and applying more scientific models and high-tech tools in effect evaluation.     

Protective effects of plant-derived natural products on renal complications

Diabetic nephropathy is the leading cause of renal failure worldwide. This debilitating disorder has several underlying pathophysiologic mechanisms, and therefore a variety of pharmacologic agents have been developed to prevent or treat diabetic nephropathy; however, synthetic drugs may possess unfavorable side effects. In response to this, the global use of herbal-based pharmacologic agents is increasing among diabetic patients. Numerous studies have reported therapeutic benefits of herbal-based compounds against diabetes-induced renal dysfunction. These agents can prevent renal dysfunction and improve renal function by blocking or suppressing deleterious pathways such as oxidative stress, inflammation, apoptosis, necrosis, and nitric oxide deprivation that lead to vascular injuries. In the current study, we have reviewed the beneficial properties of the most common herbal agents used in renal complications and diabetic nephropathy.     

继往开来,积极推动中国生物多样性科学发展——《生物多样性》创刊二十年回顾

《生物多样性》自1993年由中国科学院生物多样性委员会创办以来,一直秉承首任主编钱迎倩先生确定的刊物定位:紧跟国际热点和趋势,反映中国生物多样性科学研究进展;及时报道保护、管理和持续利用生物多样性的经验,包括法律法规和国际履约。时逢《生物多样性》创办20周年,我们总结了刊物的发展历程,分析了创刊以来策划的研究热点、报道对象、作者队伍及产生的影响,以期更好为推动中国生物多样性科学发展服务。这些年,生物多样性科学领域的热点问题,如生物入侵、全球变化下的生物多样性、DNA条形码、生物多样性监测与变化机制、谱系多样性、生物多样性信息学等,以及《生物多样性公约》及其履行进展在本刊上都得到了及时报道,2000年以后出版的13个专刊(专栏)更是热点问题的集中体现。在发表的1,189篇(不包括增刊)文章中物种多样性方面文章最多,遗传多样性方面的文章次之;从研究类群上看,植物和动物方面的文章明显多于微生物方面的文章。研究对象的地理分布则与所属地区的多样性丰富程度或受关注程度有一定的相关性。刊物目前已形成较为稳定的作者群,发表文章最多的前10位作者分别来自中国科学院(6人)、北京大学(2人)和复旦大学(2人);文章的平均作者数从1993年的约1.5人/篇增加到2011年的约4人/篇,一定程度上反映了团队合作的态势;每篇文章的平均页码数也从创刊时的平均5页左右逐渐增加到目前的10页左右,文章的信息量大大增加。发表的论文主要受国家自然科学基金、科技部项目和中国科学院项目资助,表明作者群的层次是比较高的。发表的论文中被引次数大于40的文章超过200篇,最高达970次(中国知网,2012年8月10日检索);被SCI刊物的引用次数也呈逐年递增趋势。《生物多样性》是目前我国发表生物多样性研究成果最多、影响最大、生物多样性科学领域最重要的刊物。但毋庸讳言,《生物多样性》如国内其他中文科技期刊一样,正面临巨大挑战,如优秀稿源匮乏、刊物国际化和国内评价体系的压力、如何协调基础性和应用性、如何兼顾作者和读者的需求等。针对上述问题,我们提出了对策建议,指出《生物多样性》在"立足本土的国际化"和前沿创新与基础支撑兼顾的定位下,继续提高学术质量,并通过数字化平台和新闻媒体宣传发表的重要成果等方式,提高科技信息传播效率,扎实推动中国生物多样性科学的发展。